As these are T-cell-derived neoplasms with monoclonal expression of the TCR, PAX5 is negative and is often used as a marker in differential diagnostics with other lymphomas, that morphologically overlap with ALCL, such as Hodgkin’s lymphoma, characterized by weak PAX5 expression [105]. This evidence concerns the gene PAX5 and Hodgkins lymphoma.